Mitotech
PrivateLast Round
Strategic
Jul 16, 2018
Total Funding Raised
$17M
Company Overview
Mitotech is a biotechnology company that develops novel drugs for the treatment of age-related disorders based on mitochondria-targeting cardiolipin peroxidation inhibitors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitotech Comparables
Compare Mitotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaliq | 81% | |
| Stuart Therapeutics, Inc. | 79% | |
| Aldeyra Therapeutics | 78% | |
Mitotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 16, 2018 | ||||
| VC Round | Feb 24, 2010 |
Mitotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Essex Bio-Technology | Strategic |
| Rusnano | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 101% MoM.
- Nov 8, 2025
Monthly visitors grew 89% MoM.
Mitotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mitotech's valuation, stock price, and market status.